Stay updated with breaking news from Galecto Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Galecto, Inc. (NASDAQ:GLTO – Get Free Report) was the target of a significant drop in short interest in the month of May. As of May 31st, there was short interest totalling 9,300 shares, a drop of 80.4% from the May 15th total of 47,400 shares. Approximately 0.1% of the company’s stock are short sold. Based […]
Galecto (NASDAQ:GLTO – Get Free Report) and Achaogen (OTCMKTS:AKAOQ – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, dividends, earnings, profitability and institutional ownership. Volatility and Risk Galecto has a beta of 1.26, […]
/PRNewswire/ -- The global lung cancer therapeutics market size is estimated to grow by USD 10.52 billion from 2024-2028, according to Technavio. The market is...
The potential first-in-class, oral, lysyl oxidase-like 2 inhibitor GB2064 displayed efficacy with a generally acceptable tolerability profile in the treatment of patients with myelofibrosis.
Galecto, Inc. (NASDAQ:GLTO – Get Free Report)’s stock price was up 1.8% during mid-day trading on Monday . The stock traded as high as $0.73 and last traded at $0.72. Approximately 579,002 shares traded hands during mid-day trading, an increase of 89% from the average daily volume of 307,100 shares. The stock had previously closed […]